Disclosing the mysteries of the central nervous system sanctuary for acute lymphoblastic leukemia cells

Leukemia Research

Volumn 35, Issue 6, 2011, Pages 699-700

  Pistoia, Vito ^a   Raffaghello, Lizzia ^a  

^a G GASLINI INSTITUTE   (Italy)

Author keywords

Acute lymphoblastic leukemia; Chemotherapy; Leukemic cell protection; Leukemic meningitis; Subarachnoid space microenvironment

Indexed keywords

ASPARTATE AMMONIA LIGASE; CYTARABINE; DEXAMETHASONE; HYDROCORTISONE; METHOTREXATE;

ACUTE LYMPHOBLASTIC LEUKEMIA; APOPTOSIS; ASTROCYTE; B LYMPHOCYTE; CANCER CHEMOTHERAPY; CANCER INFILTRATION; CANCER RISK; CELL SURVIVAL; CELL VIABILITY; CENTRAL NERVOUS SYSTEM; CHOROID PLEXUS; EDITORIAL; EPITHELIUM CELL; HUMAN; IMMUNOPHENOTYPING; LEUKEMIA CELL; LEUKEMIA RELAPSE; LEUKOCYTOSIS; MENINGITIS; MESENCHYMAL STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKULL IRRADIATION; T LYMPHOCYTE;

CYTARABINE; DEXAMETHASONE; HUMANS; METHOTREXATE;

EID: 79955610748     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2011.01.031     Document Type: Editorial

References (12)

1. Pui C.-H., Evans W.E. Treatment of acute lymphoblastic leukemia. N Engl J Med 2006, 354:166-178.
2. Barredo J., Ritchie A.M. Controversies in the management of central nervous system leukemia. Ped Hematol Oncol 2010, 27:329-332.
3. Jabbour E., Thomas D., Cortes J., Kantarjian H.M., O'Brien S. Central nervous system prophylaxis in adults with acute lymphoblastic leukemia. Cancer 2010, 116:2290-2300.
4. Lee C., Lin Y., Huang M., Lin C., Liu C., Chow J., et al. Increased cellular glutathione and protection by bone marrow stromal cells account for resistance of non-acute promyelocytic leukemia acute myeloid leukemia cells to arsenic trioxide in vivo. Leuk Lymphoma 2006, 47:521-529.
5. Bertrand F.E., Spengemen J.D., Shelton J.G., McCubrey J.A. Inhibition of PI3K, mTOR and MEK signaling pathways promotes rapid apoptosis in B-lineage ALL in the presence of stromal cell support. Leukemia 2005, 19:98-102.
6. Wang L., Fortney J.E., Gibson L.F. Stromal cell protection of B-lineage acute lymphoblastic leukemic cells during chemotherapy requires active Akt. Leuk Res 2004, 28:733-742.
7. Weisberg E., Wright R.D., McMillin D.W., Mitsiades C., Ray A., Barrett R., et al. Stromal-mediated protection of tyrosine kinase inhibitor-treated BCR-ABL-expressing leukemia cells. Mol Cancer Ther 2008, 7:1121-1129.
8. Mudry R.E., Fortney J.E., York T., Hall B.M., Gibson L.F. Stromal cells regulate survival of B-lineage leukemic cells during chemotherapy. Blood 2000, 96:1926-1932.
9. Vianello F., Villanova F., Tisato V., Lymperi S., Ho K.-K., Gomes A.R., et al. Bone marrow mesenchymal stromal cells non-selectively protect chronic myeloid leukemia cells from imatinib-induced apoptosis via the CXCR4/CXCL12 axis. Haematologica 2010, 95:1081-1089.
10. Ransohoff R., Kivisäk P., Kidd G. Three or more routes for leukocyte migration into the central nervous system. Nat Rev Immunol 2003, 3:569-581.
11. Uccelli A., Aloisi F., Pistoia V. Unveiling the enigma of the CNS as a B-cell fostering environment. Trends Immunol 2005, 26:254-259.
12. Akers S.M., Rellick S., Fortney J., Gibson L.F. Cellular elements of the subarachnoid space promote ALL survival during chemotherapy. Leuk Res 2011, 35:705-711.